Jakavi
Showing 1 - 25 of 41
A PMS of Jakavi® in Steroid-Refractory Graft-versus-Host Disease
Not yet recruiting
- Graft-versus-Host Disease
- ruxolitinib
- (no location specified)
Jan 11, 2023
A Prospective, Two-arm, Non-interventional Study of JAKAVI® in
Active, not recruiting
- Primary Myelofibrosis
- +2 more
- Jakavi
-
Aachen, GermanyNovartis Investigative Site
Sep 6, 2021
Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)
Completed
- Steroid Refractory GVHD
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Dec 15, 2022
Ruxolitinib for Polycythemia Vera in Patients Resistant to or
Completed
- Polycythemia Vera (PV)
- Ruxolitinib
-
East Hanover, New JerseyNovartis Investigative Site
Jun 29, 2022
Myelofibroses Trial in Saint Louis (Pevonedistat, Ruxolitinib, Peripheral blood draw)
Terminated
- Myelofibroses
- Pevonedistat
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Dec 16, 2021
Advanced Cutaneous Squamous Cell Carcinoma Trial in Atlanta, Chicago, New York (Ruxolitinib)
Recruiting
- Advanced Cutaneous Squamous Cell Carcinoma
-
Atlanta, Georgia
- +2 more
Jun 28, 2022
A Prospective, Non-interventional Study of JAKAVI® Treatment in
Active, not recruiting
- Polycythemia Vera
- Jakavi
-
Reutlingen, Baden Wuerttemberg, Germany
- +98 more
May 16, 2023
Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia Trial in Moscow, Saint Petersburg
Recruiting
- Graft-versus-host-disease
- +3 more
- Ruxolitinib
- +2 more
-
Moscow, Russian Federation
- +1 more
Apr 4, 2022
Severe/Very Severe COVID-19 Illness Trial (Ruxolitinib)
No longer available
- Severe/Very Severe COVID-19 Illness
- (no location specified)
Jan 22, 2021
COVID-19, Pneumonia Trial in Toronto (Ruxolitinib)
Terminated
- COVID-19
- Pneumonia
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Aug 13, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (Biospecimen Collection, Chest
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Biospecimen Collection
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 9, 2023
Multiple Myeloma Trial in United States (Ruxolitinib Oral Tablet [Jakafi], Lenalidomide, Methylprednisolone)
Recruiting
- Multiple Myeloma
- Ruxolitinib Oral Tablet [Jakafi]
- +2 more
-
Alhambra, California
- +12 more
Apr 18, 2022
Bone Marrow Fibrosis Trial in Germany (Allogeneic stem cell transplantation, Ruxolitinib continuous therapy)
Active, not recruiting
- Bone Marrow Fibrosis
- Allogeneic stem cell transplantation
- Ruxolitinib continuous therapy
-
Aachen, Germany
- +13 more
Aug 20, 2021
Covid-19 Trial in Marseille, Toulon (Anakinra alone (stages 2b/3), Anakinra and Ruxolitinib (overcome stage 3), Standard of
Terminated
- Covid-19
- Anakinra alone (stages 2b/3)
- +2 more
-
Marseille, Bouches-du-Rhône, France
- +2 more
Dec 11, 2020
Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk
Recruiting
- Myelofibrosis
- +2 more
- Hematopoietic stem cell transplant
- +2 more
-
Calgary, Alberta, Canada
- +4 more
Feb 16, 2021
Steroid-Refractory Acute GVHD Trial in Worldwide (T-Guard, Ruxolitinib)
Terminated
- Steroid-Refractory Acute Graft Versus Host Disease
-
Birmingham, Alabama
- +47 more
Jan 22, 2023
Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)
Suspended
- Myelofibrosis
- Ruxolitinib
- +5 more
-
Adelaide, South Australia, Australia
- +37 more
Aug 18, 2022
Chronic Phase Chronic Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blastic Phase Chronic Myeloid Leukemia Trial
Completed
- Chronic Phase Chronic Myeloid Leukemia
- +4 more
-
Toronto, Ontario, CanadaPrincess Margaret Hospital / University Health Network
Oct 29, 2020
Prostate Cancer Trial in Bellinzona (Ruxolitinib 20 MG)
Withdrawn
- Prostate Cancer
- Ruxolitinib 20 MG
-
Bellinzona, SwitzerlandIstituto Oncologico della Svizzera Italiana (IOSI)
Mar 24, 2020